Opinion/decision on a Paediatric investigation plan (PIP): Xevudy, Sotrovimab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0235/2023
P/0235/2023 : EMA decision of 14 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for sotrovimab (Xevudy), (EMEA-002899-PIP01-20-M02)
Reference Number: EMA/236247/2023
![](https://www.einpresswire.com/tracking/article.gif?t=4&a=vTlLy61AXZo52I9e&i=K8tkBqjo125k62lK)